InsiderTrades

Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/

Accepted 2022-06-27 00:00:00 ET · period of report 2022-06-23 · accession 0001747001-22-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-27 2022-06-23 KEQU Noble Ryan S. VP-Sales, Marketing-Americas M - OptEx $0.00 +955 5,018 +24% $0
D 2022-06-27 2022-06-23 KEQU Noble Ryan S. VP-Sales, Marketing-Americas F - Tax $13.82 -273 4,745 -5% -$3,773
D 2022-06-27 2022-06-23 KEQU Noble Ryan S. VP-Sales, Marketing-Americas M - OptEx $0.00 -955 5,252 -15% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-23 M A 955 $0.00 5,018 D — — (F1) Restricted stock units convert to common stock on a one-for-one basis.
2 Common Common Stock 2022-06-23 F D 273 $13.82 4,745 D — —
3 Derivative Restricted Stock Units FY21 2022-06-23 M D 955 $0.00 5,252 D — · — to — 955 Common Stock (F1) Restricted stock units convert to common stock on a one-for-one basis. (F2) On June 23, 2020, the reporting person was granted restricted stock units that vest as follows: (a) 40% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 23, 2021, subject to the reporting person's continued employment with the Company, and (b) 60% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.